Another leading US healthcare service provider has suffered a cyber attack, leading to exposure of patient data, according to TechRadar.

FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen Med
Viridian Therapeutics’ Lumvoa is approved for treating both the chronic and active phases of thyroid eye disease. This drug will offer patients an alternative to


